MétaCan
Menu
Back to cohort

Memantine (a <i>N</i>‐methyl‐<scp>d</scp>‐aspartate receptor antagonist) in the treatment of neuropathic pain after amputation or surgery: a randomized, double‐blinded, cross‐over study. (Danish Pain Research Center, University of Aarhus, Aarhus, Denmark) <i>Anesth Analg</i> 2000;91:960–966.

2001· article· en· W2049396340 on OpenAlexaboutno aff
Lone Nikolajsen, Hanne Gottrup, Anders G. D. Kristensen, Troels S. Jensen

Bibliographic record

VenuePain Practice · 2001
Typearticle
Languageen
FieldMedicine
TopicPain Mechanisms and Treatments
Canadian institutionsnot available
Fundersnot available
KeywordsMemantineMedicineNeuropathic painAnesthesiaAnalgesicNMDA receptorAllodyniaPlaceboRandomized controlled trialOpioidNociceptionHyperalgesiaSurgeryInternal medicineReceptor

Abstract

fetched live from OpenAlex

Evidence has accumulated that the N‐methyl‐d‐aspartate receptor system plays a role in continuous and stimulus‐evoked pain after nerve injury. The analgesic effect of memantine on a group of patients with chronic pain after surgery was examined in this randomized, double‐blinded, study. Nineteen patients randomly received either memantine or placebo in the first 5‐week treatment period. A washout period of 4 weeks was followed by another 5‐week treatment period of the opposite drug. The dosage of drug was increased from 5 to 20 mg/d. Pain was recorded daily, with the use of a 0‐10 numeric rating scale. Before and at the end of each treatment, pain and sensitivity were also assessed by using the McGill Pain Questionnaire, allodynia to touch, brush, and cold, wind‐up‐like pain, and thresholds to mechanical stimuli (pressure and von Frey hair). A total of 15 patients completed the study. There was no difference between memantine and placebo on any of the outcome measures. Conclude that memantine at a dosage of 20 mg/d does not reduce spontaneous or evoked pain in patients with nerve injury pain. Comment by Tat‐Leang Lee, M.D. The treatment of patients suffering from chronic neuropathic pain remains a clinical challenge, particularly in cases where opioid therapy fails to provide sufficient pain relief. Experimental data concerning the role of NMDA‐mediated processes in central sensitization and the effects of NMDA receptor antagonists in different models of neuropathic pain have been well established. Currently, clinically available NMDA antagonists have narrow therapeutic windows and are limited by psychomimetic and other side effects. There exists a need to improve on this therapeutic ratio. Potential methods include the use of more selective NMDA antagonists that modulate binding sites within the NMDA complex, using novel routes including central axis delivery, or in combination with drugs. Combinations of opioids and NMDA antagonists may hold the most promise. Recently, a 1:1 mixture of morphine with dexmethorphan hydrobromide allowed satisfactory pain relief in chronic pain patients at a significantly lower morphine dose.1 In this study, there were 3 patients who had morphine as part of their conventional treatment. Although specific data is not available, it would be interesting to know if memantine proved to be more effective in these patients.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.002
metaresearch head score (Gemma)0.001
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Randomized trial · Consensus signal: Randomized trial
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.014

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0020.001
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0020.001
Bibliometrics0.0000.000
Science and technology studies0.0000.001
Scholarly communication0.0000.001
Open science0.0010.000
Research integrity0.0010.001
Insufficient payload (model declined to judge)0.0040.001

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.054
GPT teacher head0.349
Teacher spread0.295 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designRandomized trial
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2001
Admission routes1
Has abstractyes

Explore more

Same venuePain PracticeSame topicPain Mechanisms and TreatmentsFrench-language works237,207